🇺🇸 FDA

Intelligence Platform

Patents

Browse 406 pharma-relevant patents (US and EP, A61K/A61P) linked to tracked companies. Patent cliff and LOE intelligence for BD teams.

29,054 patents indexed
patent

US 9724374

Capsule containing total flavonoids of desmodium styracifolium, method for preparing the s

WUHAN CHEMLIGAND BIO-PHARMACEUTICAL CO., LTD. · Granted Tue Aug 08 2017 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 03 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9676809

Derivatives of uridine 5′-cyclophosphate useful to treat hepatitis C viral infections

Ligand Pharmaceuticals Incorporated · Granted Tue Jun 13 2017 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 08 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9675583

Selective androgen receptor modulators (SARMS) and uses thereof

Ligand Pharmaceuticals Incorporated · Granted Tue Jun 13 2017 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 08 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9677075

Metal-ligand coordination polymer nanoparticles and methods for making

Northwestern University · Granted Tue Jun 13 2017 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 08 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9662312

Method for treating glomerulosclerosis

Ligand Pharmaceuticals Incorporated · Granted Tue May 30 2017 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 25 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9622991

Hematopoietic growth factor mimetic small molecule compounds and their uses

Ligand Pharmaceuticals Incorporated · Granted Tue Apr 18 2017 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Apr 13 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9550078

EDAR ligand derived peptides and use thereof

CAREGEN CO., LTD. · Granted Tue Jan 24 2017 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 19 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9549943

A3 adenosine receptor ligands for use in treatment of a sexual dysfunction

CAN-FITE BIOPHARMA LTD. · Granted Tue Jan 24 2017 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 19 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9539340

Bladder cancer specific ligand peptides

The Regents of the University of California · Granted Tue Jan 10 2017 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 05 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9539301

Melanotropin ligands for skin care

Arizona Board of Regents on Behalf of the University of Arizona · Granted Tue Jan 10 2017 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 05 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9492430

Methods and compositions associated with the granulocyte colony-stimulating factor recepto

Ligand Pharmaceuticals Incorporated · Granted Tue Nov 15 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 10 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9453222

Ligand-conjugated monomers

Alnylam Pharmaceuticals, Inc. · Granted Tue Sep 27 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Sep 22 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9441013

Melanocortin 1 receptor ligands and methods of use

Arizona Board of Regents on Behalf of the University of Arizona · Granted Tue Sep 13 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Sep 08 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9421254

Immunostimulatory combinations of TLR ligands and methods of use

The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Tue Aug 23 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 18 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9359285

Androgen receptor modulator compounds and methods

Ligand Pharmaceuticals Incorporated · Granted Tue Jun 07 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 02 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9345780

Site specific delivery of nucleic acids by combining targeting ligands with endosomolytic

Tekmira Pharmaceuticals Corporation · Granted Tue May 24 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 19 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9334306

Leukemia stem cell targeting ligands and methods of use

The Regents of the University of California · Granted Tue May 10 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 05 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9326991

Nucleotide prodrug compounds and use

Ligand Pharmaceuticals Incorporated · Granted Tue May 03 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Apr 28 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9304124

Compact multifunctional ligand to enhance colloidal stability of nanoparticles

United States of America as represented by the Secretary of the Air Force · Granted Tue Apr 05 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 31 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9290539

Melanotropin ligands for skin care

Arizona Board of Regents on Behalf of the University of Arizona · Granted Tue Mar 22 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 17 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9266874

Heterocycle amines and uses thereof

Ligand Pharmaceuticals Incorporated · Granted Tue Feb 23 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Feb 18 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9238069

Method of sensitizing cancer cells to the cytotoxic effects of death receptor ligands in c

The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Tue Jan 19 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 14 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9175038

Peptide mimetic ligands of polo-like kinase 1 polo box domain and methods of use

The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Tue Nov 03 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 29 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9169313

Method of treatment of cancers characterized by ligand-dependent activating mutations in F

Five Prime Therapeutics, Inc. · Granted Tue Oct 27 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 22 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

granted